Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching
NCT: NCT07195292 · NOT_YET_RECRUITING
Brief Summary
The purpose of this study is to see if a mobile-delivered mental health program called Toivoa-002, which combines digital cognitive behavioral therapy (CBT) with personal coaching, can effectively reduce depression in adults with hearing or mobility disabilities. The study aims to answer whether this dual-intervention digital service is more effective at lowering depression symptoms over an 8-week period than a "sham" digital program that is developed to look similar but does not contain active therapeutic content. The investigators hypothesize that participants who use the Toivoa-002 program will show significantly greater reductions in depression compared to those using the sham program, and that these mental health benefits will last through a 12-week follow-up. Adults within the disability community frequently encounter unique environmental and societal barriers - such as limited physical accessibility, transportation challenges, and workplace inflexibility - that can directly drive or worsen depression. By offering a fully remote and accessible mobile tool, this study seeks to determine if a digital health service can deliver scalable, effective depression relief tailored to the lived experiences of people with disabilities.
Frequently Asked Questions
What is Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching?
Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching is a clinical trial registered under NCT07195292. Current status: NOT_YET_RECRUITING.
What is the status of NCT07195292?
The current status of NCT07195292 (Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching) is: NOT_YET_RECRUITING.
When did Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching start?
Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching started on 2026-09.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.